Loading...
Market
What will be the public perception of Neuralink's N1 Implant trial by end of 2025?
1
Resolution / Starting Odds
Very Positive • 25%
Somewhat Positive • 25%
Neutral • 25%
Negative • 25%
Results from a major public opinion survey or poll conducted by a reputable organization
Story
Elon Musk's Neuralink Launches Trial for N1 Implant to Control Assistive Robotic Arm
Nov 25, 2024, 06:14 PM
Neuralink, the brain-computer interface (BCI) company founded by Elon Musk, has announced the approval and launch of a new feasibility trial. The trial will test the use of Neuralink's N1 Implant to control an assistive robotic arm. This marks an important first step in the development of brain-computer interfaces, with the potential to restore both digital and physical freedom for individuals with disabilities.
View original story
Similar markets
Successful with no issues • 25%
Successful with minor issues • 25%
Unsuccessful • 25%
Trial halted • 25%
Medical rehabilitation • 25%
Gaming • 25%
Communication • 25%
Other • 25%
Assistive technology for paralysis • 25%
Cognitive enhancement • 25%
Medical treatment for neurological disorders • 25%
Other • 25%
Yes • 50%
No • 50%
Positive outcome • 25%
Negative outcome • 25%
Inconclusive outcome • 25%
Trial not completed • 25%
Significant improvement in mobility • 25%
Moderate improvement in mobility • 25%
No improvement in mobility • 25%
Trial inconclusive • 25%
Successful with significant findings • 25%
Successful with limited findings • 25%
Unsuccessful • 25%
Indeterminate • 25%
Achieves full sensory feedback • 25%
Enables multi-device control • 25%
Significant AI integration • 25%
Other • 25%
Yes • 50%
No • 50%
Significant improvement in vision • 25%
Moderate improvement in vision • 25%
No noticeable improvement • 25%
Negative side effects • 25%
